Table 2.
Observation characteristics of study
| No of patients | 73 |
| Male (%) | 64.4 |
| Age, median (p25–p75) | 63 (51–75) |
| Total no of OE | 2314 |
| Median (range) OE per patient during the observational session (p25–p75) | 7 (5–9) |
| Total no of different drugs ordered | 213 |
| Anatomical Therapeutic Chemical medication class no (%) | |
| Gastrointestinal | 857 (37.0) |
| Anti-infective agents | 297 (12.8) |
| Blood | 286 (12.4) |
| Cardiovascular | 230 (9.9) |
| Respiratory | 171 (7.4) |
| Neurological | 171 (7.4) |
| Antineoplastic and immunomodulating agents | 116 (5.0) |
| Musculoskeletal | 73 (3.2) |
| Hormones | 57 (2.5) |
| Various | 27 (1.2) |
| Gynecological | 15 (0.6) |
| Dermatological | 6 (0.3) |
| Antiparasitic agents | 8 (0.3) |
| No (%) of OE per administration route | |
| Oral | 1560 (67.4) |
| Intravenous | 402 (17.4) |
| Inhaled | 125 (5.4) |
| Subcutaneous | 121 (5.2) |
| Continuous intravenous perfusion | 71 (3.1) |
| Transdermal | 17 (0.7) |
| Rectal | 9 (0.4) |
| Topical | 6 (0.3) |
| Intramuscular | 2 (0.1) |
| Enteral catheter | 1 (0.004) |
| No (%) of observations | |
| Morning | 1134 (49.0) |
| Evening | 1018 (44.0) |
| Night | 162 (7.0) |
| Weekend observations (%) | 33.8 |
| No (%) of observations | |
| Pharmacist | 57.3 |
| Nurse | 42.6 |
OE, opportunities for error, defined as the sum of observed administrations and omitted medications.